ESH Video


January 26, 2024


3rd Translational Research Conference



March 8-10, 2024

Vienna, Austria


Chairs: Jennifer Brown, Paolo Ghia, Michael Hallek




We are pleased to introduce our international faculty:


Do not miss the opportunity to join them
and interact with them in 6 weeks in Vienna:




About the Conference:

The 3rd ESH Tranlational Research Conference on CHRONIC LYMPHOCYTIC LEUKAEMIA is proposing a programme of leading-edge basic and clinical science where a panel of global experts in the field will provide numerous opportunities for formal and informal interactions to discuss the present and the future of CLL research. It is open to an international audience of biologists and clinicians, particularly welcoming those in-training.

This translational research conference will explore the most recent advances in the understanding of the pathogenesis and clinical management of the disease.  Open and spirited discussion on the most up-to-date information in the field is expected to understand how the many new biologic insights apply to the future of CLL.




• CLL disease progression
• Richters syndrome
• Biomarkers: where do we stand?
• Targeting the microenvironment in CLL
• What is the best time-limited therapy
• BTK inhibitors
• Small molecule resistance
• Next generation therapies
• The future: other targets


The programme will include:
Plenary Sessions - Simultaneous Meet the Experts Sessions - Brief Oral Communications
Mentored Poster Walk - Ample time for in-depth discussion.



This educational conference has been approved for 17 CME-CPD credit points
by the European Board for Accreditation in Haematology (EBAH)!


For more information, click here!



With the support of*:

Major Conference Partner

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.